Two human clinical trials on EpiCor showing immune support during the winter months – white paper

Two Randomized, double-blind placebo-controlled human clinical trials with over 100 subjects each showed significant results.

March 19, 2021

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

Already have an account?

This summary shows EpiCor® postbiotic’s effect on immune health on subjects that were both flu vaccinated and non flu-vaccinated during the winter months.

Download this white paper from Embria Health to see the results of the study.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like